- ￥498 - 4242
- TargetMol
- USA
- T1184
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
2-8°C
- 保质期：
For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -1227℃ for several months.
- 英文名：
Rivaroxaban
- 库存：
详询
- 供应商：
详询
- CAS号：
366789-02-8
- 规格：
1mg/5mg/10mg/50mg/1ml/10mM
| 规格： | 1mg | 产品价格： | ￥498.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥1087.0 |
| 规格： | 10mg | 产品价格： | ￥1701.25 |
| 规格： | 50mg | 产品价格： | ￥4242.0 |
| 规格： | 1ml/10mM | 产品价格： | ￥1088.0 |
ID：T1184
PURITY：0.98
Formula：C19H18ClN3O5S
MolWt：435.88
Appearance：白色粉末
Solubility：G4In water, 25.05 mg/L
Bioactivity：Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary.
Status：
Pathways：Angiogenesis
Target：Factor Xa inhibitor
Receptor：Factor Xa
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban
Rivaroxaban is a small-molecule, direct factor Xa inhibitor that is under investigation for the prevention and treatment of venous and arterial thrombosis. To date, oral anticoagulants have been limited largely to vitamin K antagonists
Novel Anticoagulant Therapy: Principle and Practice
(dabigatran), oral-direct factor Xa inhibitors (rivaroxaban, apixaban, YM-150, DU-176b), and tissue factor/factor VIIa complex inhibitors have been “tailor-made” to target specific procoagulant complexes and have the potential to greatly expand oral
技术资料暂无技术资料 索取技术资料
